NCT02983214View on ClinicalTrials.gov

Diabetic Artery Obstruction: is it Possible to Reduce Ischemic Events With Cilostazol?

PHASE4CompletedINTERVENTIONAL
Enrollment

826

Participants

Timeline

Start Date

November 30, 2016

Primary Completion Date

October 31, 2019

Study Completion Date

October 31, 2019

Conditions
Ischemic StrokePeripheral Artery DiseaseDiabetes Mellitus, Type 2
Interventions
DRUG

Clopidogrel

DRUG

Cilostazol

Trial Locations (1)

45110

Atherothrombosis Research Centre / Laboratory of Biochemistry, University of Ioannina, Ioannina

Sponsors
All Listed Sponsors
collaborator

LIBYTEC Pharmaceutical S.A.

UNKNOWN

lead

University of Ioannina

OTHER